v3.25.4
Non-controlling Interests - Narrative (Details)
1 Months Ended 12 Months Ended
Nov. 30, 2025
property
Dec. 31, 2025
USD ($)
property
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Sep. 30, 2021
USD ($)
$ / shares
shares
Nov. 30, 2014
USD ($)
$ / shares
shares
Noncontrolling Interest [Line Items]            
Preferred units, issued (in shares) | shares         100,000  
Preferred unit, face value (in usd per share) | $ / shares         $ 25.00  
Value of preferred OP Units | $         $ 2,600,000  
Preferred units issued (in usd per share) | $ / shares         $ 25.78  
Preferred units, redemption period   1 year        
Distributions to non-controlling interest holders | $   $ 184,000 $ 184,000 $ 185,000    
Limited partner units (in shares) | shares   405,998       405,908
Units issued to purchase building | $           $ 10,100,000
Units issued (in usd per share) | $ / shares           $ 25.00
Limited partner units, redemption period   1 year        
Payments to noncontrolling interests | $   $ 0 $ 0      
Number of properties owned | property   167        
Advisor Parent            
Noncontrolling Interest [Line Items]            
Limited partner units (in shares) | shares   90 90      
Advisor Parent | National Healthcare Properties Operating Partnership, L.P.            
Noncontrolling Interest [Line Items]            
Limited partner units (in shares) | shares   90        
Plaza Del Rio Medical Office Campus Portfolio AZ            
Noncontrolling Interest [Line Items]            
Ownership percentage purchased 4.70%          
Number of properties owned | property 4          
Ownership of property (in percentage)   100.00%        
Series A Preferred Stock            
Noncontrolling Interest [Line Items]            
Preferred stock, dividend rate, percentage   7.375% 7.375%      
Series A Preferred Unit            
Noncontrolling Interest [Line Items]            
Distributions to non-controlling interest holders | $   $ 200,000 $ 200,000      
OP Units            
Noncontrolling Interest [Line Items]            
Antidilutive securities excluded from computation of earnings per share (in shares) | shares   124,161